Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: Analysis from the ROCKET AF trial (Rivaroxaban once-daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation)

Journal of the American College of Cardiology

Volumn 61, Issue 6, 2013, Pages 651-658

  Patel, Manesh R ^a   Hellkamp, Anne S ^a   Lokhnygina, Yuliya ^a   Piccini, Jonathan P ^a   Zhang, Zhongxin ^b   Mohanty, Surya ^b   Singer, Daniel E ^c   Hacke, Werner ^d   Breithardt, Günter ^e   Halperin, Jonathan L ^f   Hankey, Graeme J ^g   Becker, Richard C ^a   Nessel, Christopher C ^b   Berkowitz, Scott D ^h   Califf, Robert M ⁱ   Fox, Keith A A ^j   Mahaffey, Kenneth W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^f MOUNT SINAI MEDICAL CENTER   (United States)

^g ROYAL PERTH HOSPITAL   (Australia)

^h BAYER CORPORATION   (United States)

ⁱ DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

more..

Author keywords

atrial fibrillation; factor Xa; rivaroxaban; stroke; warfarin

Indexed keywords

RIVAROXABAN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEATH; DRUG WITHDRAWAL; EMBOLISM; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OPEN STUDY; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; BLOOD COAGULATION; DRUG MONITORING; FACTOR XA; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MORPHOLINES; OUTCOME ASSESSMENT (HEALTH CARE); RISK ASSESSMENT; STROKE; THIOPHENES; THROMBOEMBOLISM; TIME FACTORS; WARFARIN; WITHHOLDING TREATMENT;

EID: 84873378766     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.09.057     Document Type: Article

References (10)

1. R.G. Hart, O. Benavente, R. McBride, L.A. Pearce Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis Ann Intern Med 131 1999 492 501
2. M.C. Fang, A.S. Go, Y. Chang Warfarin discontinuation after starting warfarin for atrial fibrillation Circ Cardiovasc Qual Outcomes 3 2010 624 631
3. E.M. Hylek, C. Evans-Molina, C. Shea, L.E. Henault, S. Regan Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation Circulation 115 2007 2689 2696
4. M.R. Patel, K.W. Mahaffey, J. Garg Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
5. United States Food and Drug Administration XARELTO (Rivaroxaban) tablets. Risk Evaluation and Mitigation Strategy (REMS) http://www.fda.gov/downloads/ Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ UCM295405.pdf?utm-source=fdaSearch&utm-medium=website&utm-term= Rivaroxaban box warning&utm-content=1 Accessed April 4, 2012
6. Rivaroxaban-Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study Am Heart J 159 2010 340 347
7. Effectiveness of Bridging Anticoagulation for Surgery (the BRIDGE Study) ClinicalTrials.gov http://clinicaltrials.gov/ct2/show/NCT00786474?term= bridge+trial&rank=30 Accessed April 4, 2012
8. Y.D. Kim, J.H. Lee, Y.H. Jung Effect of warfarin withdrawal on thrombolytic treatment in patients with ischaemic stroke Eur J Neurol 18 2011 1165 1170
9. L.A. García Rodríguez, L. Cea Soriano, C. Hill, S. Johansson Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study Neurology 76 2011 740 746
10. J.D. Douketis, A.C. Spyropoulos, F.A. Spencer Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e326S e350S